Granules India Ltd Q1 FY27 Results Analysis: PAT Jumps 60%, EBITDA Margin Expands 256 bps
Granules India Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,476.77 Cr (+22.04% YoY) and PAT growth of +59.77% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 21, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,476.77 Cr (+22.04% YoY) |
| PAT (Q1) | Rs. 179.96 Cr (+59.77% YoY) |
| EBITDA margin | 22.95% (+256 bps YoY) |
| EPS (Q1) | Rs. 7.26 (+56.47% YoY) |
| Market cap | Rs. 22,315.35 Cr |
| CMP | Rs. 900.55 |
Quarter Snapshot
Revenue grew 22% YoY, PAT grew 60% YoY, and EBITDA margin expanded 256 bps to 22.95%. Subsidiary operations now drive 60% of PAT, with Senn Chemicals full quarter contributing. Key catalysts include Sodium Oxybate ER FTF and Chantilly VAI clearance, while Gagillapur warning letter remains unresolved.
Key Investment Insights
Key Positives
- Consolidated revenue grew 22.04% YoY to Rs.1,476.77 Cr
- PAT grew 59.77% YoY to Rs.179.96 Cr; normalized PAT up 35.49% YoY
- EBITDA margin expanded 256 bps YoY to 22.95%
- Gross margin at 65.61%, within the top end of management's 64-65% target
- Subsidiary PAT surged 151% YoY to Rs.108.22 Cr, now 60% of consolidated PAT
- No exceptional items in Q1FY27 vs Rs.25.91 Cr charge in Q1FY26
- Finance costs fell 11.17% YoY and 35.38% QoQ, reflecting debt reduction
Risk Factors
- EBITDA margin of 22.95% missed the earlier 24-25% target, though management had stepped back from that guidance
- Gagillapur USFDA warning letter remains unresolved; no update on re-inspection timeline
- Standalone revenue declined 1.03% YoY, indicating reliance on subsidiaries for growth
- Raw material cost escalation remains a risk, though mitigated in Q1
- Effective tax rate rose to 25.14% from 22.06% in Q1FY26, partly due to base effects
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.